Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoembryonic Antigen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04154956
What this trial is testing

SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer Patients

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Sanofi 389
Not applicableUnknownNCT04999072
What this trial is testing

Carbohydrate Antigen 19-9 in Colorectal Cancer

Who this might be right for
Colorectal Cancer
Seoul National University Hospital 4,972
Early research (Phase 1)Looking for participantsNCT06663839
What this trial is testing

NILK-2301 in Patients with Locally Advanced or Metastatic Low Tumor Volume (LTV) Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Light Chain Bioscience - Novimmune SA 25
Early research (Phase 1)Study completedNCT02416466
What this trial is testing

CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases

Who this might be right for
Liver Metastases
Roger Williams Medical Center 8
Testing effectiveness (Phase 2)Ended earlyNCT05071053
What this trial is testing

Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer

Who this might be right for
Adenocarcinoma GastricGastrooesophageal Cancer
Sanofi 35
Testing effectiveness (Phase 2)Looking for participantsNCT07589517
What this trial is testing

Dual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Colorectal AdenocarcinomaUnresectable Colorectal Cancer
Beijing Biotech 48
Early research (Phase 1)WithdrawnNCT03682744
What this trial is testing

CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesColorectal Cancer+4 more
Sorrento Therapeutics, Inc.
Early research (Phase 1)Study completedNCT00217373
What this trial is testing

Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)

Who this might be right for
Adult Solid Neoplasm
National Cancer Institute (NCI) 33
Early research (Phase 1)Study completedNCT04826003
What this trial is testing

Study To Evaluate Safety, Pharmacokinetics, Pharmacodynamics, And Preliminary Anti-Tumor Activity Of RO7122290 In Combination With Cibisatamab With Obinutuzumab Pre-Treatment

Who this might be right for
Metastatic Colorectal Cancer
Hoffmann-La Roche 54
Early research (Phase 1)Ended earlyNCT02346955
What this trial is testing

Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001)

Who this might be right for
Non-small Cell Lung Carcinoma (NSCLC)MelanomaBladder Cancer+3 more
Famewave Ltd. 27
Not applicableStudy completedNCT02784028
What this trial is testing

Study in Patients With Peritoneal Carcinomatosis From CEA Overexpressing Digestive Cancer

Who this might be right for
Peritoneal Carcinomatosis
Institut du Cancer de Montpellier - Val d'Aurelle 18
Not applicableStudy completedNCT04597814
What this trial is testing

The Relationship Between the Tumor Markers and Interstitial Lung Disease

Who this might be right for
the Relationship Between the Tumor Markers and Interstitial Lung Disease Patients
The First Affiliated Hospital of Guangzhou Medical University 13
Testing effectiveness (Phase 2)Study completedNCT00004085
What this trial is testing

Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Garden State Cancer Center at the Center for Molecular Medicine and Immunology 15
Testing effectiveness (Phase 2)Ended earlyNCT05849246
What this trial is testing

The Study of Tusamitamab Ravtansine (IBI126) Combined With Sintilimab and Tusamitamab Ravtansine (IBI126) Combined With Sintilimab Plus Platinum-based Chemotherapy and Pemetrexed in Subjects With CEACAM5 Positive Expression Advanced/Metastatic Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)

Who this might be right for
Non-squamous Non-small-cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT06710132
What this trial is testing

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

Who this might be right for
Solid TumorsGastric CancerNon-Small Cell Lung Cancer (NSCLC)+2 more
EMD Serono Research & Development Institute, Inc. 184
Early research (Phase 1)Study completedNCT02350673
What this trial is testing

Intravenous (IV) Cergutuzumab Amunaleukin and Atezolizumab in Combination in Participants With Locally Advanced and/or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Hoffmann-La Roche 70
Early research (Phase 1)Ended earlyNCT00923806
What this trial is testing

Gene Therapy Using Anti-CEA Cells to Treat Metastatic Cancer

Who this might be right for
Metastatic Cancer
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Study completedNCT00003433
What this trial is testing

Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Duke Cancer Institute
Early research (Phase 1)Looking for participantsNCT07545356
What this trial is testing

KIVU-305 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Kivu Bioscience Inc. 76
Very early researchActive Not RecruitingNCT05245786
What this trial is testing

An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal CarcinomaStage III Rectal Cancer AJCC v8Stage IIIA Rectal Cancer AJCC v8+2 more
City of Hope Medical Center 14
Next Page